Today, the Jeffrey Modell Foundation (JMF), together with Baxter Healthcare Corporation, celebrated the opening of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies at the University of California?San Francisco (UCSF).
Exposure to trauma may create enough changes in the brain to sensitize people to overreact to an innocuous facial gesture years later, even in people who don?t have a stress-related disorder, says new research.
Investigators at St. Jude Children’s Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.
The Australian Therapeutic Goods Administration has recalled two ‘herbal’ medicines , Excite for women and Ultimates for men.
Researchers from the Johns Hopkins Children?s Center have found that while most pediatric residents have broached the subject of ending life support in terminally ill children, many feel neither comfortable nor sufficiently trained to discuss it.
Despite new guidelines from the U.S. Centers for Disease Control saying that all teens be routinely tested for HIV, many pediatricians continue to test only patients with high-risk behaviors, according to a study from the Johns Hopkins Children?s Center.
A small study of conversations with 26 parents of babies who died shortly after birth found that what parents said they had been told about treatment or end-of-life options was frequently at odds with what caregivers reported in the medical record.
With more than 1.4 million adults in Illinois in need of health insurance, Dr. Eric E. Whitaker, state public health director, addressed the community today at the Edgar County Health Department about the importance of having health insurance and how Governor Rod R. Blagojevich?s Illinois Covered plan addresses the healthcare crisis in the state by providing access to affordable, quality healthcare to everyone in the state.
New data in women 15 to 55 years of age show that the GlaxoSmithKline (GSK) cervical cancer candidate vaccine induces an immune response to cancer-causing human papillomavirus types 16 and 18 in the bloodstream which highly correlates to antibody levels in the cervico-vaginal secretions.
Dr. Susan Chon, associate professor in the Department of Dermatology at The University of Texas M. D. Anderson Cancer Center, knows adults and teens alike benefit from the seasonal reminder to practice key skin cancer prevention strategies.